Basic Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2071-2085
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2071
Figure 4
Figure 4 Expression levels of A20, tumor necrosis factor alpha, tumor necrosis factor receptor 1, tumor necrosis factor receptor 1-associated death domain, receptor-interacting protein 1, and FAS-associated death domain protein across groups. Data are presented as the mean ± standard deviation (n = 10). Data were evaluated for statistical significance using one-way analysis of variance and are represented as follows: aP < 0.05, bP < 0.01 as compared to normal contro; cP < 0.05, dP < 0.01 as compared to model control; eP < 0.05, fP < 0.01 as compared to mesalazine; gP < 0.05, hP < 0.01 as compared to wild type. TNFR1: Tumor necrosis factor receptor 1; RIP1: Receptor-interacting protein 1; TNF-α: Tumor necrosis factor alpha; TRADD: Tumor necrosis factor receptor 1-associated death domain; FADD: FAS-associated death domain; WT: Wild type; NC: Normal control; MC: Model control; MESA: Mesalazine; HPM: Herbs-partitioned moxibustion.